“…7 According to the patent data, 8 certain polysubstituted pyrazolo [5,1-c] [1,2,4]triazines selectively inhibit B-Raf kinase activity and are useful for treating disorders mediated by B-Raf kinase. The most concise approach to the synthesis of pyrazolo[5,1c] [1,2,4]triazine scaffolds is based on the azo-coupling of pyrazole-3(5)-diazonium salts 1 with active methylene/methine compounds followed by the intramolecular cyclization of hydrazone intermediates 2: 1,9,10 A number of 4-aminopyrazolo [5,1-c] [1,2,4]triazines were obtained by reactions of diazonium salts 1 with methylene active nitriles such as malononitrile [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] , 2-(cyanomethyl)thiazoles, 28,29 2-(cyanomethyl)benzoxazole, 19 ethyl cyanoacetate, 11,17,20,21,26,30,31 α-cyanoketones, 30,[32][33][34][35] 2-(cyanomethyl)thiadiazoles,...…”